Lument Finance (NYSE: LFT) director net sells preferred shares

Rhea-AI Filing Summary

Lument Finance Trust director Walter C. Keenan reported trading the company’s preferred stock. On March 26, 2026, he executed three open‑market sales totaling 3,600 shares at prices between $19.42 and $19.70 per share, and one open‑market purchase of 1,500 shares at $19.50 per share, resulting in a net sale of 2,100 shares of preferred stock.

Insider Trade Summary

Net Seller: 2,100 shares ($70,828)

Net Sell 4 txns

Insider Keenan Walter C

Role Director

Bought 1,500 shs ($29K)

Sold 3,600 shs ($71K)

Type	Security	Shares	Price	Value
Sale	preferred stock	3,156	$19.70	$62K
Sale	preferred stock	400	$19.50	$8K
Sale	preferred stock	44	$19.42	$854.48
Purchase	preferred stock	1,500	$19.50	$29K

Holdings After Transaction: preferred stock — 4,344 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Keenan Walter C

(Last) (First) (Middle)

C/O LUMENT FINANCE TRUST, INC.

230 PARK AVENUE, 20TH FLOOR

(Street)

NEW YORK NEW YORK 10169

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lument Finance Trust, Inc. [ LFT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
preferred stock	03/26/2026		S		3,156	D	$19.7	4,344	D
preferred stock	03/26/2026		S		400	D	$19.5	3,944	D
preferred stock	03/26/2026		S		44	D	$19.42	3,900	D
preferred stock	03/26/2026		P		1,500	A	$19.5	5,400	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Michele Halickman, Attorney-in-Fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Walter C. Keenan report for LFT preferred stock?

Walter C. Keenan reported both sales and a purchase of Lument Finance Trust preferred stock. He sold 3,600 shares in three transactions and bought 1,500 shares in one transaction, all on March 26, 2026, in open‑market trades.

How many LFT preferred shares did the director sell and at what prices?

The director sold 3,600 preferred shares of Lument Finance Trust. The open‑market sales occurred at prices between $19.42 and $19.70 per share, according to the reported Form 4 transactions for preferred stock.

Did Walter C. Keenan buy any Lument Finance Trust preferred shares in this filing?

Yes. He reported one open‑market purchase of LFT preferred stock. The transaction involved 1,500 preferred shares bought at a price of $19.50 per share on March 26, 2026, offsetting part of his same‑day sales.

What is the net share effect of Walter C. Keenan’s LFT preferred stock trades?

The set of trades resulted in a net sale of Lument Finance Trust preferred shares. He sold 3,600 shares and purchased 1,500 shares, for a net decrease of 2,100 preferred shares based on the reported Form 4 summary.

Were the LFT preferred stock transactions open‑market trades?

Yes, all reported transactions were open‑market trades. The Form 4 describes the three sales as “Sale in open market or private transaction” and the purchase as “Purchase in open market or private transaction” for the Lument Finance Trust preferred stock.